What’s new in MS: teratogenicity of disease-modifying drugs, extended interval natalizumab dosing, a potential biomarker, the “MS hug,” and virtual reality therapy.
Insights about where stem cell treatment of neurological diseases is headed.
Patients with epilepsy often seek CAM therapies—with or without the recommendations or explicit approval of their neurologist.
New guidelines reflect a growing interest in behavioral treatments and neuromodulation.
Our Editor in Chief, Heidi Moawad, MD, will be at the Neurology Times booth (No. 2151) on Monday, May 6, from noon to 1:00 PM.
Chronic pain, sleep disorders, neuropathy, and anxiety were the most common conditions that showed improvement in the study.
Obstructive sleep apnea may affect the accumulation of tau in the brain.
Take this brief quiz to test your knowledge of recent recommendations from the American Headache Society for the prevention and acute management of migraine.
Is there a connection between this patient’s ocular symptoms and migraines?
This young woman is otherwise healthy and doesn’t drink or abuse drugs. What’s in your differential diagnosis?